BCAL Diagnostics has partnered with researches in the United States to develop its blood-based breast cancer test technology.

Cancer move for local resources companies

Two Perth-based resources companies are planning to switch sectors with the acquisition of cancer-based biotechnology firms, with one planning a backdoor listing and the other seeking support for an IPO.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLPC cresa

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
58thBBX Minerals256%13%
120thSpectrum Rare Earths119%-33%
189thZenith Minerals64%-1%
431stEntek Energy5%-35%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$65k Issued
$40k Issued
$58k Issued
Total value as at the date of the transaction
Source: Morningstar


270th↑Windward Resources$46k
271st↑Entek Energy$46k
272nd↑Spectrum Rare Earths$45k
273rd↑BBX Minerals$45k
274th↓Zenith Minerals$44k
499 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Spectrum Rare Earths

1067thLeonid Charuckj$44k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer